🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ticagrelor is a potent and fast-acting P2Y12-ADP receptor antagonist recomm...
Status
Completed
Location
APHM
Start Date
2018-10-28
Trial ID
NCT03357874
Treatments Being Tested
It is a multi-center randomized clinical trial (RCT) which will enroll 3746...
Status
Unknown
Location
First Affiliated Hospital of Nanjing Medical University
Start Date
2018-02-03
Trial ID
NCT03234114
Treatments Being Tested
Along with the current clinical trial, the efficacy and safety of 180 mg lo...
Status
Completed
Location
Kafr Elsheikh University Hospital
Start Date
2021-09-01
Trial ID
NCT06120725
Treatments Being Tested
The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-20
Trial ID
NCT02293395
Treatments Being Tested
Patients with myocardial infarction, which does not include all layers of t...
Status
Completed
Location
Södersjukhuset
Start Date
2014-10
Trial ID
NCT02292277
Treatments Being Tested
The purpose of this study is to evaluate differences in the pharmacokinetic...
Status
Completed
Location
Cardiology Department, Dr. A. Jurasz University Hospital
Start Date
2016-10
Trial ID
NCT02939248
Treatments Being Tested
The primary objective of this study is to assess the pharmacodynamic (PD) e...
Status
Completed
Location
Biotrial Inc
Start Date
2018-01-24
Trial ID
NCT03430661
Treatments Being Tested
Platelets and thrombus formation play a key role in the pathogenesis of acu...
Status
Completed
Location
Attikon University Hospital
Start Date
2017-07-28
Trial ID
NCT02943369
Treatments Being Tested
Clopidogrel is the P2Y12 inhibitor of choice in PCI patients requiring OAC....
Status
Completed
Location
University of Florida
Start Date
2020-12-08
Trial ID
NCT04483583
Treatments Being Tested
Ticagrelor, a new P2Y12 receptor antagonist, achieve faster, consistent and...
Status
Unknown
Location
Shenyang Northern Hospital
Start Date
2015-10
Trial ID
NCT02578537
Treatments Being Tested